Studies in natural products chemistry / (Record no. 3013)

MARC details
000 -LEADER
fixed length control field 03111nam a22002897a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220621081853.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780128194836
040 ## - CATALOGING SOURCE
Language of cataloging Eng
Transcribing agency HITLIB
Modifying agency HITLIB
Description conventions rda
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title Eng
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number QD415.A2
Item number STU
245 ## - TITLE STATEMENT
Title Studies in natural products chemistry /
Statement of responsibility, etc. edited by Atta-ur- Rahman
264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Amsterdam :
Name of producer, publisher, distributor, manufacturer Elsevier, 1
Date of production, publication, distribution, manufacture, or copyright notice 2020.
300 ## - PHYSICAL DESCRIPTION
Extent 527 pages :
Other physical details illustrations
336 ## - CONTENT TYPE
Source rdacontent
Content type term text
Content type code txt
337 ## - MEDIA TYPE
Source rdamedia
Media type term unmediated
Media type code n
338 ## - CARRIER TYPE
Source rdacarrier
Carrier type term volume
Carrier type code nc
490 ## - SERIES STATEMENT
Series statement Studies in natural products chemistry
Volume/sequential designation 67
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Acknowledgment --<br/>Disclosure --<br/>Abbreviations --<br/>References --<br/>Chapter 2: Implications of phytochemicals as disease-modifying agents against Huntington's disease (HD): Bioactivity, a --<br/>Introduction --<br/>Huntington's disease: Clinical description and pathophysiology --<br/>Epidemiology --<br/>Genetics and molecular mechanism associated with disease onset and progression --<br/>Treatment and medication --<br/>Conventional treatments --<br/>Treatment with stem cell therapy --<br/>Alternative treatments --<br/>Anti-HD role of medicinal plants and phytochemicals --<br/>Methodology --<br/>Medicinal plants with potential anti-HD properties Bacopa monnieri (L.) Wettst. (Plantaginaceae) --<br/>Boerhaavia diffusa L. (Nyctaginaceae) --<br/>Calendula officinalis L. (Asteraceae) --<br/>Cannabis sativa L. (Cannabaceae) --<br/>Centella asiatica (L.) Urb. (Apiaceae) --<br/>Convolvulus pluricaulis Choisy (Convolvulaceae) --<br/>Garcinia kola Heckel (Clusiaceae) --<br/>Gastrodia elata Blume. (Orchidaceae) --<br/>Ginkgo biloba L. (Ginkgoaceae) --<br/>Luehea divaricata Mart. (Malvaceae) --<br/>Olea europaea L. (Oleaceae) --<br/>Panax ginseng C.A. Mey. and P. quinquefolius L. (Araliaceae) --<br/>Psoralea corylifolia L. (Fabaceae) --<br/>Punica granatum L. (Lythraceae) Bioavailability of anti-neurodegenerative natural products --<br/>Natural antioxidants as anti-HD therapeutics against neurotoxic models --<br/>Herbal formulation and their quality control --<br/>Synergistic interaction of herbal products and their possible implication against HD --<br/>Discussion --<br/>Conclusion --<br/>Abbreviations --<br/>References --<br/>Chapter 3: Amaranth: A reservoir of antioxidant-based phytonutrient for combating degenerative diseases --<br/>Introduction --<br/>Amaranth in the treatment of degenerative diseases: Some evidences
520 ## - SUMMARY, ETC.
Summary, etc. <br/>Natural products in the plant and animal kingdom offer a huge diversity of chemical structures that are the result of biosynthetic processes that have been modulated over the millennia through genetic effects. With the rapid developments in spectroscopic techniques and accompanying advances in high-throughput screening techniques, it has become possible to isolate and then determine the structures and biological activity of natural products rapidly, thus opening up exciting opportunities in the field of new drug development to the pharmaceutical industry
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Rahman, Atta-ur-
Relator term Editor
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Not for loan Home library Current library Shelving location Date acquired Source of acquisition Inventory number Total Checkouts Full call number Barcode Date last seen Copy number Koha item type
    Library of Congress Classification   Harare Institute of Technology Main Library Harare Institute of Technology Main Library General Collection 08/06/2022 Donation: Book Aid International 4205/D   QD415.A2 STU BK002516 22/07/2024 1 Books